Biogen, Inc. (BIIB)
178.30
-2.14
(-1.19%)
USD |
NASDAQ |
Dec 09, 12:38
Biogen Price: 178.30 for Dec. 9, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amgen, Inc. | 316.87 |
| Eli Lilly & Co. | 992.70 |
| Merck & Co., Inc. | 96.27 |
| Pfizer Inc. | 25.57 |
| Stoke Therapeutics, Inc. | 32.90 |
Price Related Metrics
| PE Ratio | 16.26 |
| PS Ratio | 2.698 |
| Price to Book Value | 1.437 |
| Price to Free Cash Flow | 11.56 |
| Earnings Yield | 6.15% |
| Market Cap | 26.16B |
| Operating PE Ratio | 10.72 |
| Normalized PE Ratio | 14.42 |